Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

At the moment, Pfizer's Prevnar franchise dominates the child and adult pneumococcal vaccine category, with sales of $4.85 billion in the first nine months of the year, slightly down on the same ...

Already facing one rival to its blockbuster pneumococcal vaccine Prevnar, Pfizer could have another to contend with, after Affinivax reported positive phase 2 results with its ASP3772 candidate ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

[30] Patch testing with the whole vaccine, as well as with its individual components in standardized concentrations and vehicles, was performed on the skin after resolution of the reaction.

Vaccines are responsible for the control of many infectious diseases that were once common in the United States, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German ...